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Abstract
Background: Expression quantitative trait loci (eQTLs) are likely to play an important role in the genetics of
complex traits; however, their functional basis remains poorly understood. Using the HapMap lymphoblastoid cell
lines, we combine 1000 Genomes genotypes and an extensive catalogue of human functional elements to
investigate the biological mechanisms that eQTLs perturb.
Results: We use a Bayesian hierarchical model to estimate the enrichment of eQTLs in a wide variety of regulatory
annotations. We find that approximately 40% of eQTLs occur in open chromatin, and that they are particularly
enriched in transcription factor binding sites, suggesting that many directly impact protein-DNA interactions.
Analysis of core promoter regions shows that eQTLs also frequently disrupt some known core promoter motifs but,
surprisingly, are not enriched in other well-known motifs such as the TATA box. We also show that information
from regulatory annotations alone, when weighted by the hierarchical model, can provide a meaningful ranking of
the SNPs that are most likely to drive gene expression variation.
Conclusions: Our study demonstrates how regulatory annotation and the association signal derived from eQTL-
mapping can be combined into a single framework. We used this approach to further our understanding of the
biology that drives human gene expression variation, and of the putatively causal SNPs that underlie it.
Background
Changes in gene expression are likely to play important
roles in adaptive evolution and human disease [1-5].
Much research is focused on understanding exactly how
changes in gene expression are encoded at the level of
the DNA sequence. One potentially powerful method
for dissecting this relationship is by expression quantita-
tive trait locus (eQTL) mapping [6].
Previous eQTL studies have used genetic linkage
[7-10] or association analysis [11-19] to identify regions
of the genome that contain eQTLs in a variety of differ-
ent species and cell types. Recent work has shown that
eQTLs identified in lymphoblastoid cell lines are also
substantially enriched among genome-wide association
signals, indicating that many are indeed functionally
relevant in primary tissues [20-23].
Previous studies have shown that eQTLs tend to clus-
ter near the transcription start sites (TSSs) of target
genes [14,15,17,18]; eQTLs may also be enriched within
the transcript regions of the target genes, in exons rela-
tive to introns [15], and in conserved regions [24]. How-
ever, we still know relatively little about the actual
functional context of the SNPs that produce eQTLs,
such as the extent to which these tend to occur in active
promoter or enhancer regions, in ChIP-seq peaks, or in
recognizable transcription factor (TF) binding sites.
One challenge for dissecting the functional basis of
eQTLs is that, until now, eQTL mapping in humans has
been restricted to incomplete genotype data (for exam-
ple, phase II HapMap contained approximately 30% of
common SNPs [25]). Thus, for most eQTLs, the true
causal SNPs were not included in the data sets. Second,
while it seems likely that many eQTLs disrupt regula-
tory elements or motifs, annotation of such features at a
genome-wide scale remains difficult. Finally, even with
complete sequence data and extensive regulatory anno-
tation, there is usually substantial ambiguity about
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any medium, provided the original work is properly cited.which site is actually causal for any given eQTL. This is
because the causal site is typically in linkage disequili-
brium with other nearby tag SNPs and, thus, many non-
causal SNPs are also statistically associated with gene
expression.
Here we seek to address these three issues using the
HapMap lymphoblastoid cell lines as a model system.
These cell lines represent a unique resource for our pur-
pose as they have been genotyped at more than 3 mil-
lion SNPs by the International HapMap Project [25] and
many have also been sequenced at low coverage by the
1000 Genomes Consortium [26]. In addition, one of
these cell lines is the target of extensive functional char-
acterization by the ENCODE project [27]. In this study,
we supplemented available ENCODE data with a large
set of experimentally and computationally predicted
gene regulatory elements from a variety of other
sources. Finally, we dealt with the problem of uncer-
tainty around the causal site using a Bayesian hierarchi-
cal model that estimates the enrichment of functional
sites within particular types of annotations, while
accounting for the uncertainty of which site is causal for
any given eQTL [15].
The combination of substantially increased SNP cov-
erage, genome-wide regulatory element annotation and
statistical modeling of eQTL location allowed us to
make progress towards understanding the functional
and sequence context of the genetic variants that drive
human gene expression variation at the DNA sequence
level. In addition, we show how weighting and combin-
ing regulatory annotation data can provide an informa-
tive ranking of likely functional SNPs.
Results
We analyzed gene expression data measured using Illu-
mina WG6 microarrays in 210 HapMap lymphoblastoid
cell lines from unrelated individuals, first published by
Stranger et al. [28]. Compared with other existing data
sets, these data include expression measurements for the
largest set of individuals that have been resequenced by
the 1000 Genomes Consortium and thus provide the
greatest power to identify and localize eQTLs. Following
expression data cleaning (Materials and methods) we
were left with expression measurements on 8,526 genes.
Expression normalization and removal of unknown con-
founders greatly increased our power to detect modest
associations [17,29,30] (Figure S1 in Additional file 1).
Our genotype data consisted of HapMap genotypes at
3.3 million SNPs for all 210 individuals along with addi-
tional genotype calls made by the 1000 Genomes Project
for 141 individuals. For SNPs that were called in both
the HapMap and 1000 Genomes data, we used the Hap-
Map genotype calls. The genotypes of 1000 Genomes
SNPs were imputed in the remaining 69 individuals
using BIMBAM [31,32], yielding a total of 13.6 M SNPs
per individual. For each of 8,526 expressed genes we
tested for eQTLs at all SNPs between 100 kb upstream
of the TSS and 100 kb downstream of the transcription
end site (nearly all of the compelling signals of eQTLs
in this data set lie within this region [14,15]).
In an initial analysis, we used standard linear regres-
sion to identify 2,708 eQTLs at a gene-level false discov-
ery rate (FDR) of 1% (corresponding to a P-value
threshold of P =4×1 0
-6). Of these eQTLs, 96% were
also detected using HapMap SNPs only (at the same P-
value threshold). However, in many cases, the lowest P-
value 1000 Genomes SNPs were substantially more sig-
nificant than the lowest P-value HapMap SNPs (791 of
the genes have a 1000 Genomes P-value at least an
order of magnitude smaller than the best HapMap P-
value (Figures S2A and S3 in Additional file 1)). These
observations support the expectation that HapMap
SNPs provide good power to detect eQTLs, but fre-
quently miss the functional sites.
In this paper, we will refer to an ‘eQTL’ as a locus for
which at least one SNP shows an association between
genotype and gene expression. We assume that each
eQTL can be explained by a single causal site, which we
will refer to as an ‘eQTN’ (expression quantitative trait
nucleotide). Our primary interest is in understanding
the properties of eQTNs. (In this paper we focus on the
effects of SNP variation, while recognizing that a modest
fraction of eQTLs are caused by other types of variants
such as deletions or duplications; see Materials and
methods.) In practice, however, there is usually ambigu-
i t ya st ow h i c hS N Pi sa c t u a l l yd r i v i n gt h eo b s e r v e d
association. For example, in about 80% of significant
eQTLs (at FDR = 1%) there is at least one additional
SNP with a P-value within a factor of 10 of the most
significant P-value (Figure S4A in Additional file 1).
Moreover, the distance between the significant SNPs for
a given eQTL is often tens of kilobases or more (Figure
S4B in Additional file 1). This uncertainty poses a ser-
ious difficulty for determining whether eQTLs are
enriched in any given type of functional element since
most functional elements are far smaller than the typical
extent of linkage disequilibrium.
The hierarchical model
To account for this uncertainty, we used a Bayesian
hierarchical model, similar to that previously developed
by our group [15]. Because it is usually not possible to
determine the eQTN for any given eQTL with complete
confidence, the hierarchical model instead assigns a pos-
terior probability to each SNP that it is the eQTN and
the enrichment estimates are summed over these poster-
ior probabilities. Assigning posterior probabilities allows
us to estimate the fraction of eQTNs in an annotation
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SNP is the eQTN.
In brief, the model consists of two levels (a cartoon of
this is shown in Figure 1). At the level of individual
genes, we perform Bayesian regression to test whether
the genotypes of each SNP are associated with expres-
sion of the gene [33]. The Bayesian regression yields a
Bayes factor for each SNP that measures relative support
for a model in which that SNP is the eQTN compared
to a model in which that gene has no eQTN. We also
compute a prior probability that each SNP is the eQTN,
based on a variety of annotations (for example, whether
the SNP lies within a conserved region or a DNaseI
hypersensitive site). The prior probability for each SNP
is computed as a logistic function of the SNP’s member-
ship in these annotations; the coefficients of the logistic
function (denoted by ll for annotation l) are estimated
across all genes. By combining the Bayes factors with
the prior probabilities we can compute a posterior prob-
ability that each SNP is an eQTN for a given gene.
The higher level of the hierarchical model uses all
genes with expression data to estimate the coefficients
of the logistic prior (that is, the ll). For each annotation,
we will refer to the corresponding value of ll as our
estimate of the enrichment of eQTNs in that annota-
tion, while controlling for all the other annotations
included in the model. eQTN enrichments can be inter-
preted in the same fashion as a coefficient in a logistic
regression. In our case, it is defined as the odds of a
SNP being an eQTN given that it is in a certain annota-
tion, divided by the odds if it is not in that annotation,
holding all other parameters in the model constant.
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Figure 1 A schematic outline of the hierarchical model. (a) Two SNPs that are significantly associated with expression level at the adjacent
gene (in our method, association is measured using Bayes factors). (b) SNP 1 is located in regulatory annotations I, II and III, while SNP 2 is
located in regulatory annotation I only. The numbers at the ends of the annotation bars illustrate the fold enrichment of eQTNs in each
annotation: these are the exponential of the ll parameters of the hierarchical model. In practice, enrichment levels are estimated using all the
genes simultaneously via a hierarchical model. These are combined in a logistic model to estimate the prior probability that any given SNP is an
eQTN. (c) The hierarchical model assigns a posterior probability that each SNP is an eQTN, combining information from (a, b). Thus, even though
the level of association with gene expression is similar for SNPs 1 and 2, more of the posterior probability is assigned to SNP1.
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lihood estimates of parameters of the hierarchical
model. These are computed during the maximization of
likelihood of the hierarchical model.
We fit the hierarchical model by maximizing the joint
likelihood of the expression data across all genes. This
corresponds to setting the ll to their maximum likeli-
hood estimates. At the same time, for each individual
eQTL, the posterior probabilities shift towards SNPs
that lie in annotations that are enriched for eQTNs in
other genes; the amount of shifting of the posterior is
weighted by the degree of enrichment of that annotation
genome-wide. We have previously shown with simulated
data that this approach provides accurate estimates of
the genome-wide enrichment of eQTNs within particu-
lar features, despite the uncertainty at individual genes
[15].
An additional challenge is that both eQTNs and many
regulatory annotations are nonrandomly distributed
with respect to the TSS and so eQTNs may appear
enriched in some annotations by virtue of this spatial
distribution alone. We wanted to test whether existing
regulatory annotations had explanatory power beyond
that expected from their distribution with respect to the
TSS. As part of our analysis we therefore developed a
background model that captured the effects of distance
to the TSS as well as the exon/intron structure of the
gene (Materials and methods).
For all annotations discussed in the following sections
(DNaseI, histone marks, ChIP-seq, DNaseI foot-prints,
core promoter elements and evolutionarily conserved
sites) we tested the effect of each annotation separately
within the hierarchical model, considering the annota-
tion and the background effects alone. In our final ana-
lysis (see ‘A combined model of eQTN location’ below),
we combined all annotations that were significantly
enriched in eQTNs, as detected in the first stages of our
analysis, in a single model, which we refer to as the
combined model. For all analyses using the hierarchical
model, we excluded 100 genes with strong eQTLs that
we used to test our prior model at the end of the paper
(see below for details).
eQTNs in active chromatin: DNaseI hypersensitivity and
histone modifications
DNaseI hypersensitivity and a variety of histone modifi-
cations can mark regulatory elements and regions of
active transcription or repression [34-38]. We collated
publicly available data for eight histone modifications
(H3K27ac, H3K4me1, H3K4me2, H3K4me3, H3K9ac,
H3K36me3, H3K27me3 and H4K20me1) and DNase-seq
data, all collected in HapMap lymphoblastoid cell lines
(LCLs). These data were generated by the Bernstein and
Crawford groups for the ENCODE project [39,40] and
supplemented with additional DNaseI sequencing by our
own group [41]. To analyze these data we used the hier-
archical model considering each annotation separately.
We find that SNPs located within open chromatin, as
marked by DNaseI hypersensitivity, are approximately
four-fold more likely to be associated with variation in
gene expression levels than SNPs outside these regions
(Figure 2a,c). Histone marks that have been previously
associated with active promoters and enhancers
(H3K9ac, H3K4me1, H3K4me2, H3K4me3, H3K27ac)
[35-37] are also significantly enriched in eQTNs (Figure
2a; Figure S5 in Additional file 1). In contrast, as might
be expected, there is no enrichment for eQTNs in
regions marked by the repressive marks H3K27me3 and
H4K20me1 (there is instead a weak signal of depletion,
albeit nonsignificant, of eQTNs in such regions). The
enrichment of eQTNs in regions marked by DNaseI and
active histone marks is higher (four- to seven-fold) at
distances of > 5 kb upstream of a gene’s TSS (Figure 2b;
Figure S5 in Additional file 1); the enrichment is stron-
gest for H3K27ac, a modification associated with gene
enhancers [35].
Summing over the posterior eQTN probabilities for all
eQTLs, we estimate that approximately 20% of all
eQTNs occur within DNaseI hypersensitive sites, even
though this annotation covers just 1% of the genome.
Similarly, over 40% of all eQTNs occur within either a
DNaseI hypersensitive site or within a histone-modified
region, while this combined annotation covers just 4.5%
of the genome (Table S1 in Additional file 1).
eQTNs and transcription factor binding: ChIP-seq and
DNase-seq footprints
Our analysis of regions of open chromatin suggested
that a large fraction of eQTNs impact the function of
promoters and enhancers, perhaps by modifying pro-
tein-DNA interactions that occur in these regions. We
next focused on loci of active TF binding identified
using two assays: ChIP-seq and DNase-seq footprinting.
ChIP-seq identifies fragments of DNA that are bound
by a known protein. While ChIP-seq provides binding
information for specific proteins of interest, the resolu-
tion is somewhat limited as the signal peaks may be
hundreds of base pairs in size. In contrast, individual
active TF binding sites can be mapped at the motif level
by DNase-seq footprinting [41-43]. Here the precise
location of TF binding is predicted by identifying
DNase-seq ‘footprints’ detected as protected areas of
otherwise hypersensitive regions, which mark the exact
location of protein-DNA interaction. DNase-seq foot-
printing can provide base-pair resolution of the location
of factor binding sites; however, there is frequently
ambiguity about the active binding factor if multiple fac-
tors bind to similar DNA sequence motifs. We used
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ject for nine TFs [27] as well as DNaseI-based inferences
of individual binding sites from the ‘Centipede’ algo-
rithm [41]. Binding sites were grouped into clusters
using sequence similarity (Table S2 in Additional file 1).
Interestingly, our results suggest that many eQTNs
influence binding of specific groups of TFs (Figure 3).
We find that regions bound by the TF Jun-D are highly
enriched for eQTNs (approximately 8.2-fold enrichment
above background); strong enrichment is also seen for
the immune response factor NF-B (3.3-fold) (Figure
3a). Our analysis of individual DNase-seq footprints also
shows that overall TF binding sites identified using
these methods are enriched in eQTNs (2.2-fold; Figure
3a). We also find that specific TFs and groups of TFs
are substantially more likely to produce eQTNs. Specifi-
cally, we find striking enrichments in binding sites of
the ETS family of TFs (approximately 7.5-fold enrich-
ment), interferon stimulated response elements (ISREs;
approximately 7.5-fold enrichment), CTCF binding sites
(approximately 9.4-fold enrichment) and motifs that
bind NF-B (approximately 4.5-fold enrichment). The
most enriched signal is for the ETS TF family of TFs,
which are known to be closely involved in B-cell
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and NF-B are key components of the immune
response, in particular the cellular response to viral
challenge (ISRE, NF-B, JunD) [48-50].
eQTNs within the core promoter
A large fraction of eQTNs occur very close to the TSS
[15], and presumably affect the core and distal promoter
architecture. The core promoter is usually defined as
the collection of regulatorye l e m e n t sw i t h i na p p r o x i -
mately 50 bp either side of the gene TSS, which serve to
position RNA polymerase II correctly [51,52]. We iden-
tified individual functional elements in the core promo-
ter using the following computational approaches. We
first generated annotations based on known core pro-
moter motifs, such as the TATA box and the initiator
( I n r )e l e m e n t .N e x tw em a p p e dt h el o c a t i o n so ft h e
1,000 hexamer words that are most enriched in the core
promoter versus the region immediately upstream.
Finally, we also identified evolutionarily conserved
regions [53], conserved TF binding sites [54,55], known
regulatory elements from the literature [56] and
upstream ORF-causing mutations [57] within the core
promoter region. Our results show that regions of ‘high
regulatory potential’ [58], overrepresented hexamers and
the downstream promoter element (DPE) core promoter
motif are significantly enriched in eQTNs (Figure 4a).
Interestingly, of five known core promoter elements we
included here, we find a strong enrichment in only a
single motif type, the DPE, with a suggestive but weak
enrichment in the Initiator (Inr) motif. DPE has the
consensus sequence RGWYV and is typically located 20
to 30 bp downstream of the TSS. Experimental work
has suggested that this motif may function as a TATA
box in TATA-less Drosophila promoters [59]. Perhaps
surprisingly, the remaining known core promoter motifs,
including the TATA box itself, are not predictive of
eQTN location (Figure 4b).
eQTNs in evolutionarily conserved sites
Evolutionarily conserved regions can often provide valu-
able information on the location of regulatory elements
[60,61]. We obtained phastCons conserved elements
[53], phyloP negatively selected sites [62], conserved TF
binding sites (’tfbsCons’ and ‘MotifMap’) [54,55] and
regions of high ‘regulatory potential’ [58]. In general, we
find that conservation provides surprisingly little infor-
mation for predicting eQTN location. Only the ‘regula-
tory potential’ annotation was marginally significantly
enriched in eQTNs (Figure S7 in Additional file 1). We
suggest that the relatively small effect of conservation is
a result of accounting for a distance from TSS effect in
our background model, which may diminish the utility
of conservation as an indicator of regulatory elements.
A combined model of eQTN location
Our survey of existing regulatory annotations identified
a number of computational and experimental assays
that are significantly enriched in eQTNs. We next
assembled these regulatory annotations into a single
‘combined’ model to reduce uncertainty around puta-
tively causal eQTNs. The annotations included were:
Figure 4 eQTN enrichment in regulatory elements of the core promoter. (a) The fold enrichments of eQTNs in a variety of predicted
regulatory elements based on published methods, sequence motifs and evolutionary conservation. See main text for further details. Only SNPs
occurring within 50 bp of the TSS were considered. The confidence intervals for the estimates of enrichment in other core motifs (TATA, SP1,
Initiator (Inr) and the TFIIB recognition element (BRE)) were (-∞, > 0) and are not shown. (b) The QQ-plots of expected versus observed quantiles
of the -log10(P-value) for SNPs located in several known core promoter motifs, including the TATA box, the SP1 binding site (or GC-box), the Inr
element, the BRE and the downstream promoter element (DPE), as well as in 1,000 6-mer sequences that are highly overrepresented in core
promoters.
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K3K4me2, K3K4me3 and H3K9ac histone marks; known
motifs, overrepresented hexamers and high regulatory
potential sequences at the core promoter; all the TF
ChIP-seq data; and DNase-seq footprints from the ETS,
I S R E ,C T C Fa n dN F - B TF groups. In addition to these
experimental annotations, we also included our back-
ground model, which incorporated distance from the
TSS as well as the gene structure.
When parameters are estimated from data, models
with a greater number of parameters will always pro-
duce a likelihood equal to or greater than a simpler
model and so likelihood alone cannot be used to com-
pare combined and background models, which differ in
their number of parameters. Instead, we used the Akaike
information criterion (AIC), which penalizes models
with more parameters. The model with the lowest AIC
is the best fit, and a difference of greater than two units
of AIC is typically considered significant. Using AIC,
our combined model is a significantly better fit to the
data than the background model and all the annotation
models we used in this study (Figure S8 in Additional
f i l e1 ) .T ot e s tf o ro v e r f i t t i n g ,w ea d o p t e dat e n - f o l d
cross validation approach. In cross-validation, because
no parameters are estimated from the test data, the like-
lihood can be directly used to compare these models. In
every case the combined model produces a higher likeli-
hood than the background model on the test data set
(Figure S9 in Additional file 1). This suggests that our
combined model adds significant predictive power
beyond the background model.
Many of these annotations are correlated and, as a
result, their estimated levels of enrichment shrink when
included in the same model (Figure 5). This is particu-
larly the case for many of the TF ChIP-seq peaks, only
two of which (Jun-D and NF-B) remain significant
when included along with the more generic marks of
active chromatin, namely DNaseI and the histone
marks. It is also clear that in the combined model,
some annotations are substantially more informative
than others. For example, in the region > 5kb upstream
of the TSS it seems that the best indicator of active
regions is the putative enhancer histone mark H3K27ac
[35]. The other marks add relatively little when
H3K27ac is included in the model, although when
tested individually most marks are enriched in eQTNs
(Figure S5 in Additional file 1). We note that the corre-
lations between genomic marks will be averaged over by
the model, such that the posterior probabilities will
accurately reflect the combined effects of all annotations
included.
Figure 6 illustrates how the hierarchical model com-
bines information from regulatory annotations with
Bayes factors to identify high posterior eQTNs. Here,
we selected two example high posterior eQTNs (Pr >
0.5) located in NF-B ChIP-seq regions (identified using
ENCODE data in HapMap individual NA12878). We
note that, in this case, we are specifically selecting genes
where our model places high weight on an individual
S N Pb e i n gt h ee Q T N .An a t u r a lw a yt oi d e n t i f ys u c h
SNPs is to select those where the posterior probability is
> 0.5 - in other words, our data indicate that this SNP
is more likely to be the eQTN for that gene than all
other SNPs combined. In both cases, the model selects
these SNPs because they are strongly associated with
variation in expression and they lie within a number of
enriched annotations, including DNaseI hypersensitive
regions, multiple histone marks and ChIP-seq peaks.
Independent NF-B ChIP-seq data from nine indivi-
duals [63] are shown in the bottom two panels. These
data show that, looking across individuals, the strength
of ChIP-seq signal for NF-Bi nt h i sr e g i o ni ss i g n i f i -
cantly correlated with the putative eQTN genotypes (P
=4 . 2×1 0
-3 and P =3 . 4×1 0
-4 for rs473407 and
rs28362527, respectively).
More generally, for high-confidence eQTNs within
NF-B peaks we see a significant enrichment of positive
correlation between eQTN genotype and NF-B read-
depth (P = 0.013, Kolmogorov-Smirnov test) (Figures
S10 and S11 in Additional file 1). For a large fraction of
the eQTNs that are significantly correlated with change
in binding, the direction of the change is the same as
the direction of change in expression (74%; P =6 . 3×
10
-4, sign-test), consistent with the generally accepted
role of NF-B as an activator [64]. Our results therefore
suggest that the functions of this group of eQTNs may
frequently involve changes in binding level of NF-Ba t
these locations.
Prediction of eQTN location using only prior information
The hierarchical model combines regulatory annotations
(in the form of a prior model) with the association sig-
nal derived from eQTL mapping. We tested the extent
to which this prior model (that is, excluding the associa-
tion signal) places a sensible ranking on which SNPs are
most likely to generate eQTLs. Before our analysis, we
selected 100 genes with a strong eQTL and for which
there was a single strong candidate eQTN SNP. These
genes were withheld from all analyses using the hier-
archical model. The criteria for selecting these genes
were that we required (i) at least one SNP with a P-
value < 5 × 10
-8 (this corresponds to an FDR of 0.01%),
a n d( i i )t h a tt h eP-value difference between the most
significant SNP and the next most significant SNP for
that gene be at least two orders of magnitude. This P-
value difference corresponds to requiring that the most
associated SNP has a roughly 100-fold higher Bayes fac-
tor than any other SNP for that gene.
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error, this procedure would correctly identify causal
SNPs for > 99% of genes; the corresponding rate with
realistic genotyping and imputation error rates is > 90%
(Figure S12 in Additional file 1). We may also miss some
causal variants (such as structural variants or variants in
highly repetitive regions) if they are not included in the
SNP data. Note that misidentification of the causal var-
iant will cause our analysis to be somewhat conservative,
in the sense that we will tend to underestimate the per-
formance of our prior. These genes will also tend to have
lower than average linkage disequilibrium, although this
would not seem to have any obvious biasing effect on the
performance of the prior.
I nt h ee n t i r ed a t as e t ,1 9 8g e n e sm e e tb o t hc r i t e r i a ;
the 100 genes that we used were sampled at random
from the set of 198 (see Figure S13 in Additional file 1
for examples). We then tested the ability of our prior
models to predict the location of the lowest P-value
SNP. This effectively tests whether the prior can distin-
guish low P-value SNPs using only regulatory annota-
tions, but without information on gene expression
variation.
For 50% of genes the putative causal site is among the
top 3% of SNPs in the genic region based on the prior
model, and for a large fraction (70%) the putative causal
site is ranked among the top 10% of SNPs in the region
(Figure 7). The model with experimental data is
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Page 8 of 15significantly better than the distance model alone (P =1
×1 0
-5), and both models are far better than a random
prior (P <<1 0
-16). Our results suggest that, by itself,
regulatory annotation can already provide a meaningful
selection of putative eQTNs. Combining this prior with
gene expression association signals is therefore a power-
ful approach for identifying causal variants.
Discussion
Despite its relevance, the biology underlying human
gene expression variation remains poorly understood.
To address this problem, we used genome resequencing
data from the 1000 Genomes Project to map eQTLs at
very high resolution in 210 human LCLs. Our goal was
to understand the biological mechanisms disrupted by
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Page 9 of 15these variants. We find that a substantial fraction of all
eQTNs are located in regions of active chromatin. In
addition, active binding sites for immune-related TFs
are among the most highly eQTN-enriched regions in
t h eg e n o m e .A tt h eT S S ,e Q T N sa p p e a rt of r e q u e n t l y
disrupt a known core promoter motif but not other
well-known elements such as the TATA box. Finally, we
showed that eQTNs predicted by our model are also
significantly associated with changes in NF-Bb i n d i n g ,
and that a combination of regulatory annotations per-
forms well as a prior model of eQTN location.
Open chromatin facilitates the direct interaction of
regulatory proteins or complexes with elements in the
DNA sequence. A central conclusion of our study is
that many eQTNs drive gene expression variation by
perturbing this process. In support of this we show that
eQTNs are enriched in open chromatin, in DNaseI foot-
prints and in ChIP-seq peaks. One obvious mechanism
is that eQTNs may interfere directly with protein-DNA
interactions by changing the binding affinity of the
DNA for active TFs [39,65].
Aside from altering the binding of TFs, eQTNs may
also perturb gene regulation in more subtle ways - for
example, by altering the intrinsic nucleosome prefer-
ences of the DNA [66]. eQTNs may also act epigeneti-
cally by altering the pattern of DNA methylation, with
resulting effects on gene expression [67].
The final stages of our analysis suggest that regulatory
annotation information, combined in a principled fashion,
can identify putatively functional candidate eQTNs. A
r e c e n ts t u d yb yL e eet al. [24] also addressed the related
problems of identifying causal regulators (SNPs) using a
regularized regression framework. Interestingly, Lee et al.
found that evolutionary conservation was more heavily
weighted than we observe here. One possibility is that our
background model accounts for much of this effect given
that conservation is strongly negatively correlated with dis-
tance from the TSS [68].
Figure 7 Prior rankings of SNPs for 100 genes where a single SNP is a clear best candidate for being the ‘true’ eQTN using the prior
probability from the hierarchical model. The histogram shows the percentage of genes for which the putative causal site is ranked by the
prior among the top 1 to 15 SNPs, 15 to 30 SNPs, and so on. Typically, the candidate region for each gene contains approximately 1,200 SNPs.
The two prior models correspond to the distance model only (blue) and the distance model plus experimental annotations (red). The 100 genes
analyzed here were excluded from all other analyses. BG, background.
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and high resolution training data set, our prior could
potentially be used to predict putative regulatory muta-
tions in additional cell lines and tissues. A clear applica-
tion of this would be the identification of functional
candidates from panels of putatively disease- causing
SNPs identified in genome-wide association studies.
This is of particular relevance given that high-quality
data on chromatin structure, DNA methylation and TF
binding are now available for a wide variety of cell lines
and tissues. Our model provides a straightforward
means of integrating these data and is a step towards
the goal of uncovering the regulatory architecture
underlying human genetic disease and quantitative traits.
Materials and methods
Genotype data
Our analysis focused on the 210 unrelated HapMap
phase I LCLs studied by Stranger et al. [28]. We down-
loaded 1000 Genomes genotypes for 141 of these indivi-
duals, including 44 Yoruba (YRI), 30 unrelated Japanese
(JPT), 29 unrelated Han Chinese (CHB) and 43 CEPH
(CEU), from the March 2010 SNP release of the 1000
Genomes Consortium [26]. For all HapMap SNPs we
used HapMap genotype calls from release 24 of Hap-
Map phase II [25]. We imputed genotypes for the
remaining 69 individuals using BIMBAM [31,32],
excluding SNPs with a minor allele frequency < 1%. Our
final SNP data set consisted of a total of 3.3 million
HapMap SNPs and a further 10.3 million 1000 Genomes
SNPs. For each gene we considered all SNPs in a win-
dow extending 100 kb upstream of the gene TSS and
100 kb downstream of the gene transcription end site.
Our analysis in this paper is restricted to analyzing
SNP data, and not other types of variants such as copy
number variants or indels, due to the difficulties of
incorporating these into our annotation framework.
Separate analysis that we have done indicates that these
other types of variants account for a small fraction of
eQTLs, and hence they introduce little bias into our
approach (see [15] for simulations of the hierarchical
model with missing variants).
Expression data pipeline
Expression levels in 210 LCLs were measured on the
Illumina WG6 microarray in four HapMap populations,
as described in [28]. We remapped the probes from the
array to build 36 (hg18) of the human genome using
MAQ [69], selecting only those probes that matched a
single unique location with zero mismatches. Of the
47,296 probes on the array, 41,729 fulfilled these criteria.
We next selected only those probes that overlapped an
annotated exon or exon-exon boundary, as defined in
ENSEMBL release 52 (March 2009). We found that
18,414 probes mapped to known exons, which target a
total of 15,757 genes. Of these, 10,131 probes over-
lapped one or more SNPs in our data. To remove effects
of these SNPs on probe hybridization, for each probe we
regressed expression level on the genotype of the SNP
located within the probe. In 2,122 cases this regression
was significant (P <0 . 0 5 )a n dw eu s e dt h er e s i d u a lo f
the regression as the expression measurement.
High-dimensional expression data sets are frequently
affected by a variety of unknown confounding factors
that can induce large-scale dependencies between gene
expression levels. Such dependencies can reduce power
and induce spurious associations in the data
[29,30,70,71]. Following a similar strategy to that out-
lined in [17], we calculated the first 26 principal compo-
nents (PCs) of the expression data matrix, after
centering the data within each individual. The number
of PCs was determined by first calculating PCs of 100
data sets in which expression levels were permuted with
respect to individual, to create a distribution of variance
explained under the null hypothesis of no “batch” effects
on gene expression. Using this null distribution, we cal-
culated an empirical P-value for each of the first 30
PCs, and selected only those with P < 0.05, leaving the
first 26. The expression level of each gene was fitted in
a linear regression model with population, sex and the
26 PC scores as potential covariates. The optimal num-
ber of PCs to include as covariates in each gene model
was selected by elastic net regression [72]. The tuning
parameters were selected by leave-one-out cross-valida-
tion. The residuals of this regression for each gene were
set to the quantiles of a standard normal, separately for
each population. Thus, the expression phenotypes in
our analysis were the quantile-normalized residuals of
expression level after regressing out effects of popula-
tion, sex and up to 26 PCs. Removal of PCs substantially
increased the number of eQTLs we detected in our data
set, when compared with a data set with no PCs
removed (Figure S1 in Additional file 1), and to our pre-
vious study [15]. The implementation of the elastic net
regression provided relatively slight improvement over
the analysis with 26 PCs removed for all genes. Our
expression data pipeline attempts to deal with the possi-
ble effects of population structure and expression het-
erogeneity, which can have a substantial impact on
power to detect eQTLs [29,71].
We restricted our analysis to those genes that were
expressed in LCLs, where we defined expressed genes
using RNA-seq data from a separate analysis in our lab
[17]. A gene was defined as expressed if the normalized
number of reads per site was greater than 10
-10 in over
half the individuals (71) in the RNA-seq data set (mean
number of reads per lane, 5.35 × 10
6, read length 35
and 46 bp). This arbitrary threshold was set by visual
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of reads per site across all genes and all individuals. We
removed a total of 7,231 genes that had low or zero
expression by this definition, leaving a total of 8,526
genes for analysis.
Modeling and analysis
Linear regression
In our initial analysis we used standard linear regression
to detect associations with expression, using the same
model as in our Bayesian regression analysis. The gene-
level FDR was computed by permuting the expression
data with respect to the individuals, 100 times, and
regressing the expression data on genotype in each of
the permuted data sets. This allowed us to estimate the
number of associations observed under the null hypoth-
esis of no relationship between genotype and gene
expression level [15].
The hierarchical model
The complete details of the hierarchical model are pro-
vided in Additional file 1 (Supplementary methods).
Briefly, the hierarchical model is based on a Bayesian
approach to inferring genotype-trait association, as
described in [33]. Bayes factors are used as components of
a mixture model to describe the observed expression data:
L(Yk| )= 0P0
k +( 1−  0)P1
k
where Θ are the model parameters, Π0 is the probabil-
ity that a gene does not have an eQTL, P0
k is the condi-
tional probability of the observed expression data given
that there is no eQTL, and P1
k is the conditional prob-
ability of the expression data given there is a single
eQTN. Here:
P1
k =
Mk
(j=1) πjk
where πjk is the prior probability that SNP j is the
eQTN, P1
k is the conditional probability of the data,
given that SNP j is the eQTN, and Mk is the number of
SNPs in the candidate region of gene k. Prior data, in
the form of regulatory annotations, are included using a
logistic link function:
πjk = exp(xjk)/ j’
Mk exp(xj’k)
where:
xjk = λ1δjk1 + ...+ λ1δjkl
The ll represent the additive effect of annotation l on
the log-odds of a single SNP being an eQTN and the
δjkl are indicator variables such that δjkl = 1 if a SNP is
located inside annotation l, and 0 otherwise.
Annotations
DNase-seq, ChIP-seq for transcription factor binding and
histone modifications
We generated DNase-seq data in our own group from
two additional cell lines (NA18507 and NA19239). Raw
reads from these experiments were mapped to the gen-
ome using BWA [73]. We removed reads that mapped
to more than one location in the genome, had a gapped
alignment and/or more than two mismatches to the
reference genome. To call enriched regions we imple-
mented a simple sliding window. For each 150-bp win-
dow we counted the number of reads overlapping each
site, and obtained a smoothed window average using a
Gaussian kernel (bandwidth of 50 bp). We set a window
threshold, based on Monte-Carlo simulation such that
the estimated FDR of our threshold, under a null
hypothesis of randomly distributed reads in the genome,
was < 1 × 10
-6. ChIP-seq tags typically target the ends
of ChIP fragments rather than the center [74], and
because of this, reads targeting modified histones have a
strand-specific bias in location - namely, reads on the ‘+’
strand are located 5’ of the cross-linked protein-DNA
fragment, while reads on the ‘-’ strand are located 3’ of
the fragment. We implemented a strand-specific correc-
tion by shifting the position of reads mapping to the ‘+’
strand 73 bp 3’ and reads on the ‘-’ strand 73 bp 5’.
Finally, we downloaded publicly available ChIP-seq data
from the ENCODE project (generated by the Bernstein,
Myers and Snyder groups) for the following TFs: CTCF,
C - f o s ,G A B P ,J u n - D ,M a x ,N R S F ,S R F ,a n dT A F I I .P e a k
locations for each TF were derived using MACS [74]
with the default parameter settings.
Evolutionary conservation and literature-derived elements
PhastCons conserved elements [53], PhyloP scores [62],
putatively conserved TF binding sites (tfbsCons), regula-
tory potential (RP) scores [58] and the literature-derived
regulatory elements in the OReGanno database [56]
were downloaded from the UCSC genome browser [54].
We removed all phastCons elements mapping to known
protein-coding exons prior to their inclusion in the
model and annotated all regions that had a regulatory
potential score of > 0.1 as putatively regulatory.
The core promoter
Known core promoter motifs were selected from the lit-
e r a t u r e[ 5 2 ]a n dm a p p e dt ot h er e g i o n±5 0b po ft h e
TSS of each gene. These elements included the TATA-
box (TATAAA), the GC-box or SP1 binding site
(CCCCGCCCCG), the TFIIB recognition element (BRE;
SSRCGCC) and the DPE (RGWYV). To define overre-
presented words, we compared the frequency of hexam-
ers in the region ± 50 bp of the TSS with a control
region (-100 to 50 bp upstream of the TSS). A word
was defined as overrepresented if its observed frequency
in the core promoter differed significantly from that in
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1,000 hexamers from this test (P <1 0
-10) and mapped
locations of all occurrences of these words within the
core promoter region. Upstream ORF mutations were
identified from [57].
DNaseI footprints
DNaseI footprints were taken from a previous study of
TF binding sites in LCLs [41]. Footprints were divided
into clusters based on the positional overlap of predicted
bound regions. Only clusters for which the total length
of annotated sequence (that is, concatenated sites)
exceeded 100 kb of annotated sites were included in our
analysis. Footprints can be obtained from [75].
Simulation of causal eQTLs
We used Monte-Carlo simulations to determine whether
the criteria we used to select relatively unambiguous
‘causal’ eQTNs were appropriate (namely, that the
eQTL should have at least one SNP with P <5×1 0
-8
and a minimum difference of two orders of magnitude
in P-value of the best and next best SNP). For each
simulated replicate we randomly drew a gene from the
original list of 15,757 genes. We then randomly defined
a single SNP as causal. Expression data were simulated
for that eQTN according to the linear model outlined in
the ‘Bayesian regression’ section of the Supplementary
methods in Additional file 1. The eQTN effect size was
simulated as a random draw from the mixture of normal
distributions outlined in the Supplementary methods in
Additional file 1. The probability of drawing from a
given distribution was estimated by the hierarchical
model. Next, for each individual we simulated random
normally distributed error around the genotype mean.
The variance of the error term was estimated from the
residuals of the linear regressions. We also investigated
the impact of genotyping error by randomly changing a
fraction of all genotypes according to the stated geno-
type error rates of the HapMap SNPs (0.5%) [25] or the
1000 Genomes SNPs (1 to 3%) [26]. Finally, for a variety
of thresholds we asked how often a given set of criteria
resulted in selection of a non-causal SNP as causal.
Variation in NF-B binding
We downloaded smoothed estimates of NF-B ChIP-seq
read depth in ten LCLs from the ENCODE project
[27,65]. Smoothed estimates were normalized by the
total number of reads in each lane. We identified 397
high-posterior eQTNs that also lay in NF-BC h I P - s e q
peaks identified in NA12878 and for which at least two
of the three genotypes were observed the ten individuals
analyzed in [65]. For each candidate eQTN we regressed
the read depth at the eQTN on genotype.
Data availability
All eQTLs and high-posterior eQTNs detected are avail-
able from the eQTL browser at http://eqtl.uchicago.edu/
. The source code to fit the hierarchical model, our full
data set and parameter estimates are available at: http://
eqtnminer.sourceforge.net/.
Additional material
Additional file 1: Additional material. Contains all supplementary
tables and figures, as well as supplementary methods.
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